Cargando…
Immune checkpoint inhibitors in patients with solid tumors and poor performance status: A prospective data from the real-world settings
Immune checkpoint inhibitors (ICIs) are rapidly being incorporated as treatment option either alone or in combination with chemotherapy in most of the solid tumors. Since there is very limited data of ICI in patients with poor performance status (PS) from the real world settings, we performed a retr...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021372/ https://www.ncbi.nlm.nih.gov/pubmed/33787593 http://dx.doi.org/10.1097/MD.0000000000025115 |